A B S T R A C T We have analyzed cultured skin fibroblasts derived from patients with argininosuccinate synthetase deficiency for alterations in gene structure, mRNA content, and protein structure. Genomic DNA was digested with the endonucleases EcoRI or HindIII, and the fragments were analyzed by Southern blotting and hybridization with a cDNA probe for argininosuccinate synthetase. The blot pattern is complex because there are at least 10 copies of argininosuccinate synthetase-like genes scattered over multiple human chromosomes. All nine patients studied showed patterns of DNA fragments that were indistinguishable from the normal control cell lines, and despite the possibility that the complexity could mask some changes, major deletions of the active gene(s) were not present. Blot hybridization of RNA indicated the presence of hybridizable mRNA of approximately normal size in seven of seven individuals examined with a suggestion of some heterogeneity. Analysis of enzyme antigen by protein transfer from NaDodSO4 containing polyacrylamide gels revealed considerable heterogeneity. This analysis revealed no cross-reacting material (CRM) in nine cell lines, CRM of normal molecular weight in one cell line, and CRM of reduced molecular weight in one cell line. These findings suggest that the genes for argininosuccinate synthetase in most citrullinemia patients are transcribed and produce stable mRNA. These mRNA either are not translated, or the translation product (enzyme) is rapidly degraded or is immunologically nonreactive. Defective gene expression in this disorder appears to involve abnormal mRNA, which may be altered by point mutations, frame shift mutations, deletions, insertions or particularly by abnormal RNA processing.
INTRODUCTION
Citrullinemia is an inborn error of metabolism resulting from the deficiency of argininosuccinate synthetase (E.C. 6.3.4.5) (see reference 1 for review). The enzyme is present in all tissues, but the level of enzyme activity is highest in the liver where the enzyme functions in the urea cycle for elimination of ammonia. Patients exhibit profound elevations of ammonia and citrulline in the blood. There is clinical heterogeneity within the reported cases. The majority of Caucasian patients have severe disease and present in the neonatal period with hyperammonemic coma. This form of disease usually was rapidly fatal prior to the recent development of improved dietary therapy (2) . There are cases in which a later presentation with less clinical difficulty is associated with partial enzyme deficiency, and these patients are particularly frequent in the Japanese population (3, 4) . Tedesco and Mellman (5) and Kennaway et al. (6) reported changes in the Michaelis constant (Km) values for citrulline and aspartate for the enzyme from two different patients suggesting further genetic heterogeneity within the neonatal citrullinemia group.
The availability of a specific antibody (7) and cloned cDNA probe (8) offers the opportunity for more detailed analysis of the citrullinemia mutation at the protein and nucleic acid levels. The DNA and mRNA analyses that have been carried out for the human hemoglobin abnormalities are now possible for this inborn error of metabolism. It is known that there are multiple argininosuccinate synthetase-like genes in the human genome (8) , and these genes occur on at least 10 different human chromosomes (9) . Since citrullinemia is a single gene recessive disorder, the multiple argininosuccinate synthetase-like genes may represent one or a few expressed genes and multiple pseudogenes. We Enzyme assay, antigen analysis, and incorporation of [14C] citrulline into intact cells. Argininosuccinate synthetase was assayed as described previously (10) . Antibodies to human liver argininosuccinate synthetase were prepared as described (7), and protein transfer to diazobenzyloxymethyl (DBM)' paper was conducted according to Symington et al. (11) . For incorporation of radioactive amino acids, cultured skin fibroblasts were seeded with 5X105 cells/60-ml plate. After 48 h of growth, the medium was removed, and the cells were rinsed twice with Earle's balanced salt solution followed by addition of 1 ml of radioactive medium. The radioactive medium was composed of serum-free minimal Eagle's medium without arginine and leucine. 1 ml of medium contained 0.5 gCi of ['4C]citrulline (sp act 54 mCi/ mmol) and 10 uCi of [3H]leucine (sp act 51 Ci/mmol). At the indicated times, duplicate plates were harvested and radioactivity was determined as described previously (12) .
RNA and DNA analyses. DNA was isolated from cultured cells as described by Wigler et al. (13) and total RNA was prepared as described by Wahl et al. (14) . Nucleic acids were separated on agarose gels by electrophoresis and transferred to nitrocellulose filters for DNA analysis, or to DBM paper for RNA analysis using standard methods (8) . DNA fragments and RNA molecules were detected by hybridization to the 32P-labeled 1.5 kb insert from pAS1, the plasmid containing the cDNA for argininosuccinate synthetase (8 (8) and that the genes map to at least 10 different human chromosomes (9) , including chromosome 9, X, and 6. Expression of argininosuccinate synthetase activity has been mapped to human chromosomes 9 (15) , and although we have considered this assignment open to some question (9), we believe that it is correct. We have assigned the largest 31-kb fragment in the EcoRI blot pattern and also the 3.9 kb and 2.7 kb fragments in the HindIII digest to chromosome 9. The results of this analysis for multiple citrullinemia cell lines using the restriction enzymes EcoRI and HindIII are shown in Figs. 1 below for minor differences) to the control cells and was -1,700 bases in length, which agrees with the previously determined size of the argininosuccinate synthetase mRNA (8) . Since equal amounts of total cellular RNA rather than poly(A)+RNA were applied for analysis in Fig. 3 , the relative intensity of bands should not be interpreted quantitatively. The detection of hybridizable mRNA supports the interpretation that large structural gene deletions have not occurred in these patients. Slight differences in the migration of some RNA are visible in Fig. 3 . The bands may migrate more rapidly or be broader with a faster moving component for AC, GM1679, GM3056, and GM63. In contrast, GM1044 appears indistinguishable from the normal. Although we are reluctant to overinterpret these data, preliminary S1 nuclease mapping studies suggest the differences are significant. The presence of somewhat greater relative intensity of radioactivity with the faint suggestion of bands in the region above the mature RNA (compare control 2 and AC in Fig. 3 ) could be compatible with defects in mRNA processing with excessive accumulation of processing intermediates. In other experiments, a larger minor RNA specie similar to that observed previously (8) was visible in some RNA preparations from control and disease cell lines. The nature and significance of the minor RNA component is unknown at this time, and it is at the limits of detection with RNA from cultured fibroblasts.
Immunological analysis of argininosuccinate synthetase. The presence of immunologically cross-reacting material (CRM) in cell extracts was determined after electrophoresis in NaDodSO4 containing gels and transfer to DBM paper (Fig. 4) . CRM was readily detected in all control lines but was not detectable in 9 of 11 citrullinemia cell lines examined. Only two citrullinemia cell lines (Fig. 5) gave clear evidence of the presence of an immunologically detectable protein. In cell line MV, multiple experiments revealed that the cross-reacting protein was smaller than the normal gene product, but the CRM was present in normal quantity. Cell line 1173 had less cross-reacting protein than the normal, but the product was of the same molecular weight. We were able to detect 5-10% of the normal amount of cross-reacting protein found in control fibroblasts with this analysis. One heterozygote, M.S., is shown in Fig. 4 and only a very small amount of CRM was evident. The parents of M.S. and B.S. also showed very small amounts of CRM that correlated with the low levels of enzyme activity in these cell lines. Although this study is not quantitative, it is clear that the amount of CRM present in these heterozygotes was considerably less than 50% and may be as little as 5%.
DISCUSSION
Analysis of citrullinemia cell lines at the DNA level using restriction endonuclease techniques did not re- (17) ; we would speculate that defects in RNA processing and base substitutions in mature normally processed mRNA will be the two most common categories. The frequency of processing defects may be somewhat proportional to the number of introns, both possibly being high in citrullinemia. Base substitutions in DNA can result in altered processing with net insertions and/or deletions in the improperly spliced RNA. Abnormal processing of RNA is now documented in detail for many thalassemia mutations (18) (19) (20) . Deletions, insertions, and frameshift mutations at a DNA level are also possible explanations for the findings reported here.
The results obtained from the immunological studies provided clear evidence of heterogeneity within the citrullinemia cell lines. Only 2 of the 11 cell lines tested showed any evidence of CRM. Interestingly, one of these cell lines (1173) has been shown to be a kinetic mutant by Kennaway et al. (6) . Cell line GM63, which has also been reported to be a kinetic mutant (5, 6), does not show any evidence of cross-reactive protein. This apparent discrepancy may be due to the presence of a very labile protein in this cell line or a mutation that has altered the primary recognition site for the antibody being used. Patient M.V. presents a different mutation. The quantity of cross-reacting protein appears normal and is -2,000-3,000 daltons smaller than the normal argininosuccinate synthetase monomer. We have no data on the parents of this patient.
Of the possible explanations for the absence of crossreacting immune material in the presence of mRNA, rapid degradation is an attractive possibility, since it might explain the unusually low argininosuccinate synthetase levels in some heterozygotes studied here and reported previously (21) . Because human argininosuccinate synthetase is a tetramer (7), the association of a mutant subunit with normal subunits might result in an unstable tetramer with a short half-life. This would also explain the very low level of CRM observed in our heterozygous cell lines. Such interactions can occur even if the original mutant produces no detectable CRM, and the effect on wild type subunits presumably indicates that the mutant is capable of producing subunits despite the failure to detect antigen. For CRM+ citrullinemia patients, it is possible that enzyme composed of mixed tetramers would not be degraded, and heterozygotes could have high or low levels of enzyme activity based on the catalytic properties of the mixed tetramers. Observations of this type are well documented for the dimeric alkaline phosphatase from Escherichia coli (22) and for the octameric glutamate dehydrogenase from Neurospora crassa (23) . Significantly less than 50% of normal levels of activity have been reported for heterozygotes for a number of human recessive disorders including orotic aciduria (24) , cystathionine synthase deficiency (25) , and adenine phosphoribosyl transferase deficiency (26) .
